Regulatory Roundup: FDA Issues Statement for Consumers about Antibiotic Use
FDA Issues Statement for Consumers about Antibiotic Use
Last week, FDA urged consumers to be “smart” about the way they use antibiotics. “Antibiotics can be used to treat bacterial infections; however, they are commonly over-prescribed. Patients sometimes ask their healthcare professional to prescribe antibiotic drugs for viral infections, like the common cold, despite the fact that they will not work and may lead to potentially harmful side effects,” said the agency in a Nov.15, 2010, online announcement. FDA specifically advised that patients take their medicine as prescribed, not save antibiotics for future use, and not use antibiotics that are prescribed for other individuals.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
